HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey A Ecsedy Selected Research

Jeffrey A Ecsedy Research Topics

Disease

22Neoplasms (Cancer)
01/2020 - 03/2007
3Neuroblastoma
03/2017 - 02/2013
3Melanoma (Melanoma, Malignant)
06/2016 - 01/2015
2Neurofibrosarcoma (MPNST)
03/2017 - 09/2012
2Hematologic Neoplasms (Hematological Malignancy)
06/2015 - 05/2014
2Glioblastoma (Glioblastoma Multiforme)
05/2014 - 02/2012
2Glioma (Gliomas)
05/2014 - 02/2012
2Aneuploidy (Aneuploid)
04/2013 - 06/2007
1Brain Neoplasms (Brain Tumor)
01/2020
1Retinoblastoma (Glioblastoma, Retinal)
01/2020
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2015
1Triple Negative Breast Neoplasms
09/2014
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2014
1Anemia
06/2014
1Leukopenia
06/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2014
1Multiple Myeloma
06/2014
1Neutropenia
06/2014
1Thrombocytopenia (Thrombopenia)
06/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2014
1Ovarian Neoplasms (Ovarian Cancer)
05/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2014
1Carcinogenesis
01/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2013
1Papilloma (Papillomatosis)
04/2013
1Carcinoma (Carcinomatosis)
04/2013
1Medulloblastoma
02/2013
1Leukemia
02/2013
1Neurofibromatosis 1 (Neurofibromatosis Type I)
09/2012
1Neurofibroma
09/2012
1Oligodendroglioma
02/2012
1Epilepsy (Aura)
02/2012
1Astrocytoma (Pilocytic Astrocytoma)
02/2012
1Lymphoma (Lymphomas)
12/2011

Drug/Important Bio-Agent (IBA)

14MLN 8237IBA
01/2020 - 12/2011
14Aurora Kinase AIBA
03/2017 - 03/2007
6Aurora KinasesIBA
12/2015 - 02/2011
4MLN8054IBA
02/2011 - 03/2007
3Heme (Haem)IBA
01/2015 - 06/2014
3Pharmaceutical PreparationsIBA
06/2014 - 02/2012
2Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 09/2014
2RNA (Ribonucleic Acid)IBA
06/2016 - 04/2013
2Biomarkers (Surrogate Marker)IBA
06/2016 - 02/2011
2Biological ProductsIBA
01/2015 - 05/2014
2Proteins (Proteins, Gene)FDA Link
09/2012 - 02/2012
1Cyclin-Dependent Kinase 6IBA
01/2020
1Circulating Tumor DNAIBA
01/2020
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2015
1SurvivinIBA
12/2015
1Death Domain ReceptorsIBA
12/2015
1LigandsIBA
12/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2015
1Drug CombinationsIBA
01/2015
1Docetaxel (Taxotere)FDA Link
09/2014
1Antineoplastic Agents (Antineoplastics)IBA
09/2014
1AgarIBA
05/2014
1Temozolomide (Temodar)FDA LinkGeneric
05/2014
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2013
1VorinostatFDA Link
02/2013
1Small Interfering RNA (siRNA)IBA
09/2012
1Neurofibromin 1 (Neurofibromin)IBA
09/2012
1Messenger RNA (mRNA)IBA
02/2012
1TubulinIBA
12/2011
1DNA (Deoxyribonucleic Acid)IBA
12/2011
1Antimitotic AgentsIBA
02/2011
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
10/2008

Therapy/Procedure

7Therapeutics
03/2017 - 02/2011
2Drug Therapy (Chemotherapy)
05/2014 - 09/2012
2Oral Administration
06/2007 - 03/2007
1Immunotherapy
06/2016